AC Immune reports Phase 2 data showing stabilized Parkinson's biomarkers, strong antibody response, and a potential slowing ...
AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s DiseaseResults show, for the ...
In addition to ALS, pridopidine is in late-stage clinical development for HD, with Prilenia and Ferrer planning to initiate a confirmatory study in HD designed to confirm pridopidine's effects and ...
Sport Fishing Mag on MSN
The evolution of outboard engines
From high horsepower to alternative fueling options, modern outboard engines are evolving down multiple paths. The post The ...
Becker is a serious, progressive neuromuscular condition that is X-linked, affecting approximately one in 18,000 male ...
A complete breakdown of the modifications includes Golf R Euro R20 LED taillights with rear fog light priced at $750 from ECS ...
Biogen Canada Inc. is encouraged by the recent Health Technology Assessment (HTA) evaluations issued by Canada’s Drug Agency ...
FDA clearance received to start the pivotal, 500-patient, placebo-controlled Phase 3 "PREVAiLS" study of pridopidine in participants with early, rapidly progressive ALS; US recruitment set to begin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback